Innovative Plant-Based Medicine Set to Transform Inflammatory Disease Treatments in the US Market LONDON, March 22, 2023 /PRNewswire/ — MGC Pharmaceuticals Ltd. (LSE: MXC), (ASX: MXC), (OTC: MGCLF), a European based bio-pharma company specializing in the development and supply of…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.